Form 4: Arteris Director Sells Shares Under 10b5-1 Trading Plan

Arteris director Saiyed Atiq Raza sold 2,776 shares of common stock at an average price of $12.3366 per share on January 6, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

• Saiyed Atiq Raza, a director at Arteris, Inc., sold 2,776 shares of common stock on January 6, 2025.
• The sale was executed under a 10b5-1 trading plan adopted on June 6, 2024.
• The shares were sold at a weighted average price of $12.3366, with individual transaction prices ranging from $12.19 to $12.56.
• Following the transaction, Mr. Raza directly owns 19,287 shares and indirectly owns 684,320 shares through the Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust.

Sentiment

Score: 5

Explanation: The document reports a routine insider sale under a pre-arranged plan, which is neither positive nor negative in itself. The sentiment is neutral.

Risks

• Sales by insiders can sometimes be perceived negatively by the market, potentially impacting the stock price.

Industry Context

Insider trading activity is a common occurrence in publicly traded companies, and these transactions are closely monitored by regulators and investors.

Comparison to Industry Standards

• The use of 10b5-1 trading plans is a standard practice for corporate insiders to avoid accusations of trading on non-public information.
• The reported sale is within the normal range of insider transactions and does not appear to be unusual compared to similar filings from other companies.

Stakeholder Impact

• The sale may have a minor impact on shareholder sentiment, but it is unlikely to cause a significant change in the stock price given the pre-planned nature of the transaction.

Key Dates

Keywords

Arteris, insider trading, Form 4, stock sale, 10b5-1 plan, Saiyed Atiq Raza, director